APA (7e ed.) Bronvermelding

Zhou, X., Cai, G., Mao, S., Xu, D., Xu, X., Zhang, R., & Yao, Z. (2020). Modulating NMDA receptors to treat MK-801-induced schizophrenic cognition deficit: Effects of clozapine combining with PQQ treatment and possible mechanisms of action. BMC.

Chicago (17e ed.) Bronvermelding

Zhou, Xingqin, Gangming Cai, Shishi Mao, Dong Xu, Xijie Xu, Rongjun Zhang, en Zhiwen Yao. Modulating NMDA Receptors to Treat MK-801-induced Schizophrenic Cognition Deficit: Effects of Clozapine Combining with PQQ Treatment and Possible Mechanisms of Action. BMC, 2020.

MLA (9e ed.) Bronvermelding

Zhou, Xingqin, et al. Modulating NMDA Receptors to Treat MK-801-induced Schizophrenic Cognition Deficit: Effects of Clozapine Combining with PQQ Treatment and Possible Mechanisms of Action. BMC, 2020.